These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Comparative studies on hepatic DNA alkylation in rats by N-nitrosomethylethylamine and N-nitrosodimethylamine plus N-nitrosodiethylamine.
    Author: von Hofe E, Kleihues P.
    Journal: J Cancer Res Clin Oncol; 1986; 112(3):205-9. PubMed ID: 3782259.
    Abstract:
    The purpose of this study was to determine whether quantitative differences in hepatic DNA methylation or ethylation are sufficient to explain differences in the carcinogenicity of N-nitrosomethylethylamine (NMEA), N-nitrosodimethylamine (NDMA), and N-nitrosodiethylamine (NDEA). Methylation and ethylation of hepatic DNA were determined in male Fischer 344 rats following a single IP dose of NMEA, NDMA, NDEA or an equimolar mixture of NDMA plus NDEA. The total nitrosamine dose ranged from 0.05 to 0.25 mmol/kg. After 5 h survival, hepatic DNA was extracted by adsorption onto hydroxyapatite. Acid hydrolysates were analyzed by cation exchange HPLC with fluorescence detection. DNA methylation by NMEA (170 mumol O6-methylguanine/mol guanine at 0.1 mmol/kg) was comparable to that observed in animals given an equimolar mixture of NDMA plus NDEA, indicating that NMEA is one-half as effective a methylating agent as NDMA. In contrast, the amount of ethylation by NMEA (5.9 mumol O6-methylguanine/mol guanine at 0.1 mmol/kg) was approximately 4 times less than that observed in animals treated with an equimolar mixture of NDMA and NDEA. The presence of NDEA had little effect on DNA methylation by NDMA, suggesting that neither synergism nor competition occurs in the simultaneous activation of these two nitrosamines. The role of beta-hydroxylation of NMEA as a metabolic pathway that reduces the extent of DNA ethylation is discussed.
    [Abstract] [Full Text] [Related] [New Search]